These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7578369)

  • 21. 13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13).
    Cui SX; Zhang HL; Xu WF; Qu XJ
    Eur J Pharmacol; 2014 Jul; 734():50-9. PubMed ID: 24726845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
    Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
    J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates.
    Yang Y; Zhou Z; He S; Fan T; Jin Y; Zhu X; Chen C; Zhang ZR; Huang Y
    Biomaterials; 2012 Mar; 33(7):2260-71. PubMed ID: 22189143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P(HPMA)-block-P(LA) copolymers in paclitaxel formulations: polylactide stereochemistry controls micellization, cellular uptake kinetics, intracellular localization and drug efficiency.
    Barz M; Armiñán A; Canal F; Wolf F; Koynov K; Frey H; Zentel R; Vicent MJ
    J Control Release; 2012 Oct; 163(1):63-74. PubMed ID: 22613881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymer water-soluble derivatives of polypeptide antibiotic, gramicidin-S based on reactive copolymers of N-(2-hydroxypropyl) methacrylamide.
    Solovskij M; Panarin E
    J Control Release; 1999 Mar; 58(1):1-8. PubMed ID: 10021484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of N-acyl-2-(5-fluorouracil-1-yl)-D,L-glycine as a colon-specific prodrug of 5-fluorouracil.
    Lee JS; Jung YJ; Kim YM
    J Pharm Sci; 2001 Nov; 90(11):1787-94. PubMed ID: 11745736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pinocytic uptake and intracellular degradation of N-(2-hydroxypropyl)methacrylamide copolymers. A potential drug delivery system.
    Duncan R; Rejmanova P; Kopecek J; Lloyd JB
    Biochim Biophys Acta; 1981 Nov; 678(1):143-50. PubMed ID: 7306576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and in vitro testing of methotrexate carrier conjugates linked via oligopeptide spacers.
    Fitzpatrick JJ; Garnett MC
    Anticancer Drug Des; 1995 Jan; 10(1):1-9. PubMed ID: 7695810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.
    Seymour LW; Ulbrich K; Wedge SR; Hume IC; Strohalm J; Duncan R
    Br J Cancer; 1991 Jun; 63(6):859-66. PubMed ID: 1648946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and in vitro anti-tumor activity of novel HPMA copolymer-drug conjugates with potential cell surface targeting property for carcinoma cells.
    Xiang Q; Yang Y; Zhou Z; Zhou D; Jin Y; Zhang Z; Huang Y
    Eur J Pharm Biopharm; 2012 Feb; 80(2):379-86. PubMed ID: 22101181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes.
    Ríhová B; Etrych T; Pechar M; Jelínková M; Stastný M; Hovorka O; Kovár M; Ulbrich K
    J Control Release; 2001 Jul; 74(1-3):225-32. PubMed ID: 11489498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration.
    Yang YW; Lee JS; Kim I; Jung YJ; Kim YM
    Eur J Pharm Biopharm; 2007 May; 66(2):260-7. PubMed ID: 17182232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.
    Line BR; Mitra A; Nan A; Ghandehari H
    J Nucl Med; 2005 Sep; 46(9):1552-60. PubMed ID: 16157540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformationally restricted formyl methionyl tripeptide chemoattractants: a three-dimensional structure-activity study of analogs incorporating a C alpha,alpha-dialkylated glycine at position 2.
    Toniolo C; Crisma M; Valle G; Bonora GM; Polinelli S; Becker EL; Freer RJ; Sudhanand ; Rao RB; Balaram P
    Pept Res; 1989; 2(4):275-81. PubMed ID: 2520765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled biodegradability of polymers--a key to drug delivery systems.
    Kopecek J
    Biomaterials; 1984 Jan; 5(1):19-25. PubMed ID: 6375745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodegradable microspheres. 17. Lysosomal degradation of primaquine-peptide spacer arms.
    Borissova R; Stjärnkvist P; Karlsson MO; Sjöholm I
    J Pharm Sci; 1995 Feb; 84(2):256-62. PubMed ID: 7738812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysosomal degradability of poly(alpha-amino acids).
    Chiu HC; Kopecková P; Deshmane SS; Kopecek J
    J Biomed Mater Res; 1997 Mar; 34(3):381-92. PubMed ID: 9086408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degradation of side chains of N-(2-hydroxypropyl) methacrylamide copolymers by lysosomal enzymes.
    Duncan R; Lloyd JB; Kopecek J
    Biochem Biophys Res Commun; 1980 May; 94(1):284-90. PubMed ID: 7387696
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers.
    Lammers T; Kühnlein R; Kissel M; Subr V; Etrych T; Pola R; Pechar M; Ulbrich K; Storm G; Huber P; Peschke P
    J Control Release; 2005 Dec; 110(1):103-18. PubMed ID: 16274831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification.
    Chytil P; Etrych T; Konák C; Sírová M; Mrkvan T; Ríhová B; Ulbrich K
    J Control Release; 2006 Sep; 115(1):26-36. PubMed ID: 16899320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.